Rcs Willits Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 99 S Humboldt St, Willits, CA 95490 Phone: 707-459-9900 Fax: 707-459-9904 |
Manzanita Services, Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 286 School St, Willits, CA 95490 Phone: 707-463-0405 |
Substance Use Disorders Treatment Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 125 E Commercial St Ste 200, Willits, CA 95490 Phone: 707-472-2637 Fax: 707-472-2657 |
Sextant Consulting Services, Inc. Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 3435 Williams Ranch Rd, Willits, CA 95490 Phone: 707-322-3202 |
Tapestry Family Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 286 School St, Willits, CA 95490 Phone: 707-463-3300 |
Tapestry Family Services, Inc. Clinic - Adolescent and Children Mental Health Medicare: Not Enrolled in Medicare Practice Location: 733 S Main St, Willits, CA 95490 Phone: 707-463-3300 |
News Archive
Poor-quality sleep marked by frequent awakenings can speed cancer growth, increase tumor aggressiveness and dampen the immune system's ability to control or eradicate early cancers, according to a new study published online January 21, 2014, in the journal Cancer Research.
Kidney failure affects 25 million individuals in the U.S. and many more throughout the world. Loss of kidney function means the majority of these patients must undergo dialysis treatments to remove excess fluids and waste products. Although dialysis therapy coupled with medication has improved the life expectancy for people with kidney failure, for unknown reasons, patients' risk of sudden heart failure and death remains 10 to 20 times greater than average.
Researchers at the Perelman School of Medicine at the University of Pennsylvania report that a short course of vaccination with an anti-HER2 dendritic cell vaccine made partly from the patient's own cells triggers a complete tumor eradication in nearly 20 percent of women with ductal carcinoma in situ (DCIS), an early breast cancer.
Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th PLoS ONE.
Researchers at the University of California, San Diego School of Medicine say a protein essential to regulating cell cycle progression - the process of cell division and replication - activates a key tumor suppressor, rather than inactivating it as previously thought.
› Verified 9 days ago